Skip to main content
OpenTrials

Clinical trial condition

Nodal Marginal Zone Lymphoma

Explore clinical trials studying Nodal Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

17 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Nodal Marginal Zone Lymphoma trial results

Recruiting

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

NCT05700149

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of Miami Miami, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Weill Cornell Medical New York, United States
  • Ohio Health Riverside Methodist Hospital Columbus, Ohio, United States
View all 50 locations
View Trial Details
Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

NCT05544019

Conditions
ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations
  • Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States
  • Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States
  • Napa Research Pompano Beach, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Recruiting

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

NCT04223765

Conditions
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Active, not recruiting

MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas

NCT03697512

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • CHU UCL Namur / site Godinne Yvoir, Belgium
  • CHU de Tours - Hôpital Bretonneau Tours, Cedex 01, France
  • CHU de Montpellier Montpellier, Cedex 05, France
  • CHU d'Estaing Clermont-Ferrand, Cedex 1, France
View all 36 locations
View Trial Details

Related conditions